Trial · NCT02771977
Results by group46
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 46
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percentage of Patients With Progression of AKI OR Dialysis OR Death | Usual Care | 639 | Participants | ||
| Percentage of Patients With Progression of AKI OR Dialysis OR Death | Drug-specific Alert | 585 | Participants | ||
| Percentage of Patients for Whom Any One of the Targeted Medications is Discontinued | Usual Care | 1413 | Participants | ||
| Percentage of Patients for Whom Any One of the Targeted Medications is Discontinued | Drug-specific Alert | 1547 | Participants | ||
| 14- Day Mortality Rate | Usual Care | 282 | Participants | ||
| 14- Day Mortality Rate | Drug-specific Alert | 253 | Participants | ||
| Inpatient Mortality Rate | Usual Care | 365 | Participants | ||
| Inpatient Mortality Rate | Drug-specific Alert | 356 | Participants | ||
| Percentage of Patients Who Receive Dialysis Within 14 Days of Randomization | Usual Care | 127 | Participants | ||
| Percentage of Patients Who Receive Dialysis Within 14 Days of Randomization | Drug-specific Alert | 123 | Participants | ||
| Percentage of Patients on Inpatient Dialysis | Usual Care | 137 | Participants | ||
| Percentage of Patients on Inpatient Dialysis | Drug-specific Alert | 151 | Participants | ||
| Percentage of Patients Discharged on Dialysis | Usual Care | 105 | Participants | ||
| Percentage of Patients Discharged on Dialysis | Drug-specific Alert | 127 | Participants | ||
| Percentage of Patients With AKI Progression From Stage 1 to Stage 2 | Usual Care | 248 | Participants | ||
| Percentage of Patients With AKI Progression From Stage 1 to Stage 2 | Drug-specific Alert | 242 | Participants | ||
| Percentage of Patients With AKI Progression From Stage 2 to Stage 3 | Usual Care | 256 | Participants | ||
| Percentage of Patients With AKI Progression From Stage 2 to Stage 3 | Drug-specific Alert | 231 | Participants | ||
| AKI Duration | Usual Care | 1.1 | Inter-Quartile Range 0.8 to 2.2 | days | |
| AKI Duration | Drug-specific Alert | 1 | Inter-Quartile Range 0.8 to 2.1 | days |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02771977/results